2024-10-16 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**1. Performance Comparison:**

CVS Health Corp (CVS) is a healthcare company that operates pharmacies, health insurance plans, and a variety of healthcare services. Its stock performance has lagged significantly behind the S&P 500 (VOO) over the period analyzed. 

* **Cumulative return:** CVS: -29.13%, VOO: 135.82%.
* **Performance Gap:** -164.95%.
* **Relative Gap:** 1.5 (meaning CVS is currently at the 1.5% percentile in terms of historical performance compared to the S&P 500).

**2. Recent Price Movement:**

* **Closing price:** $66.63
* **5-day moving average:** $66.16
* **20-day moving average:** $61.51
* **60-day moving average:** $59.29

CVS's price is currently above all three moving averages, suggesting potential for further upward movement. However, the 5-day average is relatively close to the current price, indicating potential for short-term correction.

**3. Technical Indicators:**

* **RSI:** 85.99 - This suggests CVS is in overbought territory, indicating potential for a short-term correction.
* **PPO:** 0.99 - A high PPO value indicates a strong uptrend.
* **Delta_Previous_Relative_Divergence:** 0.49 -  This indicates a potential for short-term downside.
* **Expected_Return:** 0.0% -  This implies that CVS is not expected to outperform the S&P 500 over the next five years, based on current data and analysis.

**4. Recent Earnings and Outlook:**

CVS has shown a consistent ability to meet or exceed earnings expectations in recent quarters.

| Date       | EPS   | Expected EPS |
| ---------- | ----- | ------------ |
| 2024-08-07 | 1.83  | 1.73         |
| 2024-05-01 | 1.31  | 1.7          |
| 2024-02-07 | 2.12  | 2.01         |
| 2023-11-01 | 2.21  | 2.13         |
| 2023-08-02 | 2.21  | 2.12         |

The most recent earnings report (2024-08-07) showed a beat of $0.10 per share, demonstrating a positive outlook for the company. 

**5. News and Recent Issues:**

* **Recent Market Outlook:** CVS is facing challenges in the current market due to ongoing inflationary pressures, rising healthcare costs, and potential for slowing economic growth.
* **Analyst Opinions:** Analyst sentiment is generally bullish on CVS, with many analysts expecting the company to continue to deliver solid earnings and maintain a strong market position. 
* **Performance Highlights:** CVS is focusing on growth through expansion of its pharmacy network, expanding into new healthcare services, and increasing digital capabilities. The company is also working to manage costs and improve efficiency.

**6. Overall Analysis:**

CVS is a well-established company with a strong market position. However, the stock has underperformed the market significantly in recent years. Despite positive recent earnings and analyst sentiment, concerns remain about the company's ability to navigate challenges in the current market environment. Technical indicators suggest potential for a short-term correction, while the expected return is currently at 0%. Investors should carefully consider these factors and conduct thorough due diligence before investing in CVS.

**7. Key Takeaways:**

* CVS Health Corp has underperformed the S&P 500 significantly in recent years.
* CVS is currently in overbought territory and may experience short-term correction.
* The company has consistently delivered positive earnings results, exceeding expectations in recent quarters.
* CVS faces challenges in the current market, including inflationary pressures and rising healthcare costs.
* The stock is expected to deliver a 0% return over the next five years, based on current data and analysis. 
